Open an account

Cronos Group

CRON · TORONTO

$3.35−$0.095 (−2.76%)TodayMarket closed ·
Prev close $3.45

About CRON

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The firm distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.

Employees
626
Headquarters
TORONTO, Ontario
Listed
May 7, 2014
Sector
Health Care
Industry
Pharmaceuticals
Website
thecronosgroup.com

CRON key statistics

Market cap
1.78B
Price-earnings ratio
17.23
Dividend yield
—
Average volume
905.11K
Volume
815.97K
Open price
$3.43
High today
$3.43
Low today
$3.30
52 Week high
$3.61
52 Week low
$2.28

Cronos Group (CRON) at a glance

As of Oct 23, 2026, Cronos Group (CRON) shares are priced at $3.35, giving the company a market cap of 1.78B and a price-to-earnings ratio of 17.23.

Today the stock has traded between $3.30 and $3.43. The current price is 1.5% above the day's low and 2.3% below its high.

Volume so far is 815.97K shares, in line with the average of 905.11K shares a day.

Over the past year Cronos Group has ranged from $2.28 to $3.61, and now sits 81% of the way up that range.

Cronos Group met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.09 per share against an estimate of $0.00.

The average analyst price target is $4.74, 41.5% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $4.74
Low
$4.33
Now
$3.35
High
$5.26

CRON earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 335.6% on average.

  1. Q3 FY24: reported $0.02 per share against an estimate of -$0.0102
  2. Q4 FY24: reported $0.11 per share against an estimate of -$0.0068
  3. Q1 FY25: reported $0.02 per share against an estimate of $0.00
  4. Q2 FY25: reported -$0.10 per share against an estimate of -$0.0204
  5. Q3 FY25: reported $0.08 per share against an estimate of $0.00
  6. Q4 FY25: reported -$0.004 per share against an estimate of $0.0102
  7. Q1 FY26: reported $0.04 per share against an estimate of $0.00
  8. Q2 FY26: reported $0.09 per share against an estimate of $0.00

CRON news

  • Avi Kapoor

    Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

  • Press releaseGlobe Newswire

    Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada

  • Press releaseGlobe Newswire

    Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange

  • Kaustubh Bagalkote

    Why Akanda Stock Is Surging Wednesday?

  • Akanksha Bakshi

    Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change

  • 'Trump Reclassifies State-Licensed Medical Marijuana As A Less-Dangerous Drug In A Historic Shift' - AP News

  • Mohd Haider

    Akanda (AKAN) Stock Continues Soaring Overnight Amid Trump Cannabis Reclassification Report: What You Should Know

  • Press releasePRNewswire

    Format Innovation Reshapes a $438B Functional Market

Similar companies

Companies in the same industry as Cronos Group

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.